PET scan imaging in oncology

被引:71
作者
Jerusalem, G
Hustinx, R
Beguin, Y
Fillet, G
机构
[1] CHU Sart Tilman, Div Hematol & Med Oncol, Dept Med, B-4000 Liege, Belgium
[2] Univ Liege, Div Nucl Med, Dept Med, B-4000 Liege, Belgium
关键词
fluorodeoxyglucose; positron emission tomography; staging;
D O I
10.1016/S0959-8049(03)00374-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
With the emergence of positron emission tomography (PET) from research laboratories into routine clinical use, it is important to redefine the most appropriate use of each imaging technique. The aim of this review article is to show the potential of PET in oncology. We discuss the most promising indications and the perspectives for the future. We will also point out the shortcomings and the important questions to be answered before fully considering PET as a necessary tool in the day-to-day practice of oncology. Although many studies have documented the high accuracy of F-18-FDG PET for the detection and staging of malignant tumours and for the monitoring of therapy results in these patients, it is very important to assess the impact of the technique on patient outcome and to show cost-effectiveness from the societal viewpoint. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1525 / 1534
页数:10
相关论文
共 50 条
  • [31] PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
    Joachim Brumberg
    Johannes Tran-Gia
    Constantin Lapa
    Ioannis U. Isaias
    Samuel Samnick
    Annals of Nuclear Medicine, 2019, 33 : 69 - 77
  • [32] PET imaging of noradrenaline transporters in Parkinson's disease: focus on scan time
    Brumberg, Joachim
    Tran-Gia, Johannes
    Lapa, Constantin
    Isaias, Ioannis U.
    Samnick, Samuel
    ANNALS OF NUCLEAR MEDICINE, 2019, 33 (02) : 69 - 77
  • [33] Trends in PET Scan Usage for Imaging of Patients Diagnosed With Nonmetastatic Urologic Cancer
    Adejoro, Oluwakayode
    Alishahi, Amin
    Soubra, Ayman
    Konety, Badrinath
    CLINICAL GENITOURINARY CANCER, 2016, 14 (01) : 38 - +
  • [34] Positron emission tomography (PET) and PET/CT for guiding therapy in oncology
    Haug, A. R.
    Bartenstein, P.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (10) : 468 - 472
  • [35] PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area
    Verger, Antoine
    Kas, Aurelie
    Darcourt, Jacques
    Guedj, Eric
    CANCERS, 2022, 14 (05)
  • [36] What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review
    Zhang-Yin, Jules Tianyu
    Girard, Antoine
    Bertaux, Marc
    CANCERS, 2022, 14 (04)
  • [37] Dynamic whole-body FDG-PET imaging for oncology studies
    Tamaki, Nagara
    Kotani, Tomoya
    Nishimura, Motoki
    Kaji, Tomohito
    CLINICAL AND TRANSLATIONAL IMAGING, 2022, 10 (03) : 249 - 258
  • [38] Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology
    Verma, Vivek
    Choi, J. Isabelle
    Sawant, Amit
    Gullapalli, Rao P.
    Chen, Wengen
    Alavi, Abass
    Simone, Charles B., II
    SEMINARS IN RADIATION ONCOLOGY, 2018, 28 (03) : 171 - 177
  • [39] PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging
    Balyasnikova, Svetlana
    Lofgren, Johan
    de Nijs, Robin
    Zamogilnaya, Yanna
    Hojgaard, Liselotte
    Fischer, Barbara M.
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 2 (04): : 458 - 474
  • [40] Molecular Imaging in Oncology: 18F-Sodium Fluoride PET Imaging of Osseous Metastatic Disease
    Mick, Curtis G.
    James, Trent
    Hill, Jacqueline D.
    Williams, Patrick
    Perry, Mark
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 203 (02) : 263 - 271